SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

23 Apr 2020 07:00

RNS Number : 5653K
Devro PLC
23 April 2020
 

23 April 2020

 

Devro plc

 

Trading Update

 

This announcement contains inside information

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January 2020 to the current date ahead of its Annual General Meeting on 30 April 2020.

The Group remains focused on protecting the well-being of its employees, their families and the wider community. Our teams have responded well to the Covid-19 crisis and their efforts and dedication have resulted in us being able to maintain the safety and continuity of our global operations.

Current trading and Covid-19 impacts

Q1 2020 edible collagen volumes increased by c. 2% compared to the prior year, driven by continued execution of growth initiatives and elevated short-term demand relating to Covid-19.

Emerging markets were up 13% led by strong growth in Latin America, Russia and East and South East Asia. Mature markets declined 3% mainly due to ongoing distributor destocking in Continental EU & West and a weaker demand environment during January and February in the UK & Ireland. North America continued to grow.

Our people are working hard to service customers in the food supply chain and all sites are currently operating. We continue to closely monitor Covid-19 developments with the key risks being preserving supply chain continuity and employee well-being, together with the potential for the nature and duration of global containment measures to affect demand. In recent weeks some suppliers have experienced disruption in their end markets. We acted decisively to secure supply, but this has resulted in some raw material inflation, which we are working to mitigate through targeted cost savings.

The Group has also instigated cash mitigation actions in response to Covid-19, including cutting all discretionary capital and operating expenditure. The company is currently not taking advantage of any Covid-19 UK government support schemes.

Financial position

Devro has a strong financial position with substantial liquidity and long-term banking facilities. The Group's debt facilities consist of a committed £105 million Revolving Credit Facility (RCF), which expires in 2023, and US$100 million of private placements expiring in 2021 (US$25 million), 2024 (US$50 million) and 2026 (US$25 million). As of Friday 17 April 2020, the Group had net debt of £130 million, comprising gross debt of £156 million and cash of £26 million. As at the date of this announcement the Group has available liquidity of c. £59 million comprising of cash and undrawn committed facilities.

Dividend

The Board is mindful of the uncertainty as to the potential for future disruption as a result of Covid-19. As a precautionary measure the Board has therefore decided to delay payment of its 2019 final dividend by withdrawing the proposed recommendation to pay a final 2019 dividend of 6.3 pence per share (c.£10.5 million cash cost) from the resolutions being put at the AGM on 30 April. Based on the Board's current knowledge, it intends to pay an additional interim dividend of the same amount in the second half of 2020. The Board will keep this under review as the Covid-19 pandemic unfolds.

Outlook

Despite our good volume growth performance in Q1, we do not envisage any change to prior volume guidance for 2020. As such, and absent any negative Covid-19 impact, the Board's expectation for good progress in 2020 is unchanged.

Devro is a global business, integrated into the crucial food supply chain and has a robust balance sheet leaving it well positioned to succeed in these uncertain times.

 

 

ENDS

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain / Nick Hasell

Tel: 07909 684 466

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEMFWEESSEEL
Date   Source Headline
6th Oct 20157:00 amRNSCompletion of acquisition
6th Aug 20153:51 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSINTERIM RESULTS
27th Jul 20152:53 pmRNSListing Rule 9.6.14(R) Disclosure
10th Jul 20157:00 amRNSAcquisition
9th Jun 201511:43 amRNSHolding(s) in Company
1st Jun 20157:00 amRNSTotal Voting Rights
28th May 20152:44 pmRNSHolding(s) in Company
28th May 20152:41 pmRNSHolding(s) in Company
26th May 20158:16 amRNSBlock Listing Six Monthly Return
7th May 20155:10 pmRNSDirector/PDMR Shareholding
29th Apr 20154:15 pmRNSResult of AGM
29th Apr 20157:00 amRNSTrading Update
27th Mar 20157:00 amRNSChange of Auditor
27th Mar 20157:00 amRNS2014 Annual Report
26th Mar 20154:00 pmRNSDirector/PDMR Shareholding
5th Mar 20153:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20152:34 pmRNSDirector Dealings
3rd Mar 20157:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
3rd Dec 20144:19 pmRNSBlock Listing Six Monthly Return
21st Oct 201411:27 amRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSInterim Management Statement
6th Oct 20141:39 pmRNSHolding(s) in Company
29th Aug 201411:23 amRNSTotal Voting Rights
7th Aug 20149:04 amRNSHolding(s) in Company
1st Aug 20142:38 pmRNSDirector/PDMR Shareholding
30th Jul 20147:00 amRNS2014 Interim Results
19th Jun 201410:03 amRNSHolding(s) in Company
10th Jun 20145:00 pmRNSDirector/PDMR Shareholding
30th May 201411:18 amRNSHolding(s) in Company
30th May 20147:00 amRNSTotal Voting Rights
29th May 201410:13 amRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSBlock Listing Six Monthly Return
16th May 201411:01 amRNSDirector/PDMR Shareholding
15th May 20149:00 amRNSConfirmation of Board Change
13th May 20145:16 pmRNSDirector/PDMR Shareholding
8th May 201411:49 amRNSHolding(s) in Company
7th May 20147:00 amRNSFurther Information on US Private Placement
1st May 20142:12 pmRNSDirector Dealings
30th Apr 20144:48 pmRNSResult of AGM
30th Apr 20148:27 amRNSTotal Voting Rights
30th Apr 20147:01 amRNSAppointment of Chairman
28th Apr 20147:00 amRNSInterim Management Statement
24th Apr 20144:43 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSAnnual Financial Report
21st Mar 201411:12 amRNSAdditional Listing
17th Mar 20142:54 pmRNSHolding(s) in Company
10th Mar 201410:54 amRNSHolding(s) in Company
10th Mar 201410:26 amRNSHolding(s) in Company
5th Mar 20144:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.